U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07119073) titled 'In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted)' on April 25.
Brief Summary: The primary purpose of this study is to assess the effect of food on the rate and extent of absorption and the overall bioavailability of a single dose of CTx-1301 50 mg trimodal tablets in healthy adult volunteers.
Study Start Date: Oct. 31, 2024
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers in Fed and Fasted State
Intervention:
DRUG: Dexmethylphenidate
Subjects will be randomized to one of two sequences. Subjects will be dosed with 50 mg dose of Cox-1301 during each sequence. Subjects will serve as their own con...